The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness

Anticancer Research

Volumn 18, Issue 5 A, 1998, Pages 3433-3437

  Ginestra, Angela ^a   La Placa, Maria Dorotea ^a   Saladino, Francesca ^a   Cassarà, Donata ^a   Nagase, Hideaki ^b   Vittorelli, Maria Letizia ^a,c  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c Centre of Experimental Oncobiology   (Italy)

Author keywords

Matrix metalloproteinases; Membrane vesicles; Shedding; Tumour invasion; Urokinase type plasminogen activator

Indexed keywords

CASEIN; GELATIN; GELATINASE A; GELATINASE B; MATRIGEL; UROKINASE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MEMBRANE VESICLE; METASTASIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

BREAST NEOPLASMS; COLLAGEN; COLLAGENASES; CULTURE MEDIA; DRUG COMBINATIONS; ENDOSOMES; FEMALE; GELATINASES; HUMANS; LAMININ; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTEOGLYCANS; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031760355     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Tarin D: Fine structure of murine mammmary tumors: the relationship between epithelium and connective tissue in neoplasm induced by various agents. Br J Cancer 23: 417-425, 1969.
2. Taylor DD and Black PH: Shedding of plasma membrane fragments. Neoplastic and developmental importance. In: Developmental Biology 3 (Steinberg M, ed). New York, Plenum Press, 1986, pp 33-57.
3. Dainiak N: Surface membrane-associated regulation of cell assembly, differentiation and growth. Blood 78: 264-276, 1991.
4. Dolo V, Adobati E, Canevari S, Picone MA, and Vittorelli ML: Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens. Clin Exp Metastasis 13: 277-286, 1995.
5. Van Blitterswijk WJ, De Veer G, Krol JH and Emmelot P: Comparative lipid analysis of purified plasma membranes and shed extracellular membrane vesicles from normal murine thymocytes and leukaemia GRSL cells. Bioch Bioph Acta 688: 496-504, 1982.
6. Lerner MP, Lucid SW, Wen GI and Nordquist RE: Selected area membrane shedding by tumor cells. Cancer Lett 20: 125-130, 1983.
7. Dolo V, Ginestra A, Cassarà D, Violini S, Lucania G, Nagase H, Pavan A and Vittorelli ML: Selective localization of MMP-9, ß1 integrins and HLA-I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Submitted, 1998.
8. Dainiak N and Sorba S: Intracellular regulation of the production and release of human erytroid-directed lymphokines. J Clin Invest 87: 213-220, 1991.
9. Cassarà D, Ginestra A, Dolo V, Miele M, Caruso G, Lucania G, and Vittorelli ML: Modulation of vesicle shedding in 8701 BC human breast carcinoma cells. J Submicr Cytol Pathol 30: 45-53, 1998.
10. Poste G and Nicolson GL: Arrest and metastasis of blood-born tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci U.S.A. 77: 399-403, 1980.
11. Taylor D D and Black PH: Inhibition of macrophages Ia antigen expression by shed plasma membrane vesicles from metastatic murine melanoma lines. J Natl Cancer Inst 74: 859-867, 1985.
12. Dolo V, Pizzurro P, Ginestra A and Vittorelli ML: Inhibitory effect of vesicles shed by human breast carcinoma cells on lymphocyte 3H-thymidine incorporation, are neutralised by anti TGF-B antibodies. J Submicr Cytol Pathol 27: 535-541, 1995.
13. Dolo V, Ginestra A, Ghersi G, Nagase H and Vittorelli ML: Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities. J Submicr Cytol Pathol 26: 173-180, 1994.
14. Ginestra A, Monea S, Seghezzi G, Dolo V, Nagase H, Mignatti P and Vittorelli ML: Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT-1080 fibrosarcoma cells. J BiolChem 272: 17216-17222, 1997.
15. Nagase H, Barrett AJ and Woessner JF jr: Nomenclature and glossary of the matrix metalloproteinases. Matrix suppl 1: 421-424, 1992.
16. Danø K, Andreasen PA, Grøndhal-Hansen J, Kristensen B, Nielsen LS and Skriver L: Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44: 146-239, 1985.
17. Mignatti P and Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161-195, 1993.
18. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370: 61-65, 1994.
19. Cao J, Sato H, Takino T and Seiki M: The C-terminal Region of Membrane Type Matrix Metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem 270: 801-805, 1995.
20. Menashi S, Dehem M, Souliac I, Legrand Y and Fridman R: Density-dependent regulation of cell surface association of matrix metalloproteinase 2 (MMP-2) in breast carcinoma cells. Int J Cancer 75: 259-265, 1998.
21. Minafra S, Morello V, Glorioso F, La Fiura A, Tomasino RM, Feo S, Mcintosh D, and Wolley DE: A new cell line (8701-BC) from primary ductal infiltrating carcinoma of human breast. Br J Cancer 60: 185-192, 1989.
22. Heussen C and Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substates. Anal Biochem 102: 196-202, 1980.
23. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245, 1987.
24. Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL and Thorgeisson UP: Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis 12: 168-174, 1992.
25. Noel AC, Polette M, Lewalle JM, Munaut C, Emonard HP, Birembaut P and Foidart JM: Coordinate enhancement of gelatinase A mRNA and activity levels in human fibroblasts in response to breast-adenocarcinoma cells. Int J Cancer 56: 331-336, 1994.